Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Tox21_300270.

Client Email

Product

Tox21_300270
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Tox21_300270

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 17 USDMF, 12 CEP/COS, 9 JDMF, 3 EU WC, 8 KDMF, 4 NDC API, 10 Listed Suppliers, $ API Reference Price

26 API Suppliers
17 USDMF
12 CEP/COS
9 JDMF
3 EU WC
8 KDMF
4 NDC API
10 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

442 FDF Dossiers, 78 FDA Orange Book, 234 Europe, 51 Canada, 36 Australia, 27 South Africa, 16 Listed Dossiers

442 FDF Dossiers
78 FDA Orange Book
234 Europe
51 Canada
36 Australia
27 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 23 SPI Pharma, 3 DKSH, 2 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 2 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 11 Corel Pharma Chem, 6 DFE Pharma, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 50 Direct Compression, 47 Coating Systems & Additives, 36 Disintegrants & Superdisintegrants, 30 Granulation, 28 Lubricants & Glidants, 25 Controlled & Modified Release, 22 Co-Processed Excipients, 20 Thickeners and Stabilizers, 20 Chewable & Orodispersible Aids, 17 Taste Masking, 15 Solubilizers, 10 API Stability Enhancers, 9 Parenteral, 9 Film Formers & Plasticizers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Topical, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

91 Fillers, Diluents & Binders
50 Direct Compression
47 Coating Systems & Additives
36 Disintegrants & Superdisintegrants
30 Granulation
28 Lubricants & Glidants
25 Controlled & Modified Release
22 Co-Processed Excipients
20 Thickeners and Stabilizers
20 Chewable & Orodispersible Aids
17 Taste Masking
15 Solubilizers
10 API Stability Enhancers
9 Parenteral
9 Film Formers & Plasticizers
6 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
3 Topical
3 Rheology Modifiers
2 Surfactant & Foaming Agents

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 228 Finished Drug Prices, 1 Annual Reports

1 US Medicaid Prescriptions
228 Finished Drug Prices
1 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 6 JP, 5 Others

3 EDQM
4 USP
6 JP
5 Others

$ API Ref.Price (USD/KG) : 620 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling Lafleur Henderson LLP

filter Patent Reset all filters

4 All

01 41323836

filter Product Reset all filters

4 All

01 4Pravastatin Sodium

filter Dosage Reset all filters

4 All

01 3Tablet

02 1Tablets

filter Exp Date Reset all filters

4 All

01 42010-11-02

Product Main Page

01

Gowling Lafleur Henderson LLP

Pravastatin

Formnext Forum

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Pravastatin

Formnext Forum

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Pravastatin

Formnext Forum

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 40mg

Dosage Form : Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Lafleur Henderson LLP

Pravastatin

Formnext Forum

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Pravastatin

Brand Name : PRAVACHOL

Patent Number : 1323836

Filing Date : 1989-02-16

Strength per Unit : 80 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-11-02

Date Granted : 1993-11-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?